Companies: 10,795·Total market cap: $144.5T
Item 9 Labs Corp.

Item 9 Labs Corp.

INLBOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$70181
P/E Ratio
52W High$0.0001
52W Low$0.0001

Item 9 Labs Corp. (INLB) Revenue

Annual & quarterly revenue history · segment & region breakdown

INLB · revenue · updated Jun 9, 2026

Core revenue metrics

Item 9 Labs Corp. trailing twelve-month (TTM) revenue is $0.02B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.02B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$203K
97 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Item 9 Labs Corp. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
INLB revenue by year · INLB revenue history · INLB annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Item 9 Labs Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Item 9 Labs Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Item 9 Labs Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

INLB revenue · 4 questions

INLB's trailing twelve-month (TTM) revenue is $0.02B. That is an increase of 0.00% year-over-year from — in FY.

INLB revenueINLB annual revenuewhat is INLB revenueINLB TTM revenue

Source: FMP · Item 9 Labs Corp. SEC filings · GAAP · Item 9 Labs Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026